Business Description
![Roche Holding AG Roche Holding AG logo](https://static.gurufocus.com/logos/0C000008TT.png?14)
Roche Holding AG
NAICS : 325412
SIC : 2834
ISIN : CH0012032113
Share Class Description:
XSWX:RO: Bearer SharesDescription
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.19 | |||||
Debt-to-EBITDA | 1.95 | |||||
Interest Coverage | 12.11 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.38 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.7 | |||||
3-Year EBITDA Growth Rate | -4.7 | |||||
3-Year EPS without NRI Growth Rate | -1 | |||||
3-Year FCF Growth Rate | 1.2 | |||||
3-Year Book Growth Rate | -4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 5.24 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.68 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.5 | |||||
9-Day RSI | 62.26 | |||||
14-Day RSI | 61.48 | |||||
6-1 Month Momentum % | 19.85 | |||||
12-1 Month Momentum % | 6.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 180.6 | |||||
Days Sales Outstanding | 70.09 | |||||
Days Payable | 86.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.15 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 1.8 | |||||
Forward Dividend Yield % | 3.15 | |||||
5-Year Yield-on-Cost % | 3.58 | |||||
3-Year Average Share Buyback Ratio | 2.2 | |||||
Shareholder Yield % | 0.92 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.1 | |||||
Operating Margin % | 24.27 | |||||
Net Margin % | 17.53 | |||||
FCF Margin % | 18.73 | |||||
ROE % | 37.58 | |||||
ROA % | 11.77 | |||||
ROIC % | 16.85 | |||||
ROC (Joel Greenblatt) % | 54.73 | |||||
ROCE % | 22.29 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.39 | |||||
Forward PE Ratio | 16.82 | |||||
PE Ratio without NRI | 15.14 | |||||
Shiller PE Ratio | 20.4 | |||||
Price-to-Owner-Earnings | 19.92 | |||||
PEG Ratio | 12.62 | |||||
PS Ratio | 3.75 | |||||
PB Ratio | 7.8 | |||||
Price-to-Tangible-Book | 137.39 | |||||
Price-to-Free-Cash-Flow | 20.05 | |||||
Price-to-Operating-Cash-Flow | 14.12 | |||||
EV-to-EBIT | 17.68 | |||||
EV-to-Forward-EBIT | 12.87 | |||||
EV-to-EBITDA | 14.32 | |||||
EV-to-Forward-EBITDA | 11.23 | |||||
EV-to-Revenue | 4.19 | |||||
EV-to-Forward-Revenue | 4.16 | |||||
EV-to-FCF | 22.36 | |||||
Price-to-Projected-FCF | 1.42 | |||||
Price-to-DCF (Earnings Based) | 1.01 | |||||
Price-to-DCF (FCF Based) | 1.34 | |||||
Price-to-Median-PS-Value | 0.86 | |||||
Price-to-Graham-Number | 9.63 | |||||
Earnings Yield (Greenblatt) % | 5.66 | |||||
FCF Yield % | 4.98 | |||||
Forward Rate of Return (Yacktman) % | 7.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Roche Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 60,581 | ||
EPS (TTM) (CHF) | 13.24 | ||
Beta | 0.71 | ||
Volatility % | 21.35 | ||
14-Day RSI | 61.48 | ||
14-Day ATR (CHF) | 4.309349 | ||
20-Day SMA (CHF) | 302.45 | ||
12-1 Month Momentum % | 6.38 | ||
52-Week Range (CHF) | 229.4 - 312 | ||
Shares Outstanding (Mil) | 796.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Roche Holding AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Roche Holding AG Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Roche Holding AG Frequently Asked Questions
What is Roche Holding AG(XSWX:RO)'s stock price today?
The current price of XSWX:RO is CHF305.00. The 52 week high of XSWX:RO is CHF312.00 and 52 week low is CHF229.40.
When is next earnings date of Roche Holding AG(XSWX:RO)?
The next earnings date of Roche Holding AG(XSWX:RO) is 2025-01-31 Est..
Does Roche Holding AG(XSWX:RO) pay dividends? If so, how much?
The Dividend Yield %  of Roche Holding AG(XSWX:RO) is 3.15% (As of Today), Highest Dividend Payout Ratio of Roche Holding AG(XSWX:RO) was 0.59. The lowest was 0.43. And the median was 0.49. The  Forward Dividend Yield % of Roche Holding AG(XSWX:RO) is 3.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |